Over the past decade, proxy contests have gone from a once rare phenomenon to a standard feature of the Canadian corporate world and as the number of contests have increased, so too have activists’ success rates. To some extent these
May 2014
Activist Pershing Square Teams Up With Valeant Pharmaceuticals To Target Allergan Inc.
![Photo of Andrea Campbell](https://nortonroseplatform.com/wp-content/uploads/sites/17/userphoto/764-1714594986.thumbnail.jpg)
By Andrea Campbell on
Shareholder activism has been dubbed “the new M&A” in recognition of activists’ propensity to drive companies to pursue value-creating transactions. Last month, Bill Ackman’s Pershing Square Capital Management took this trend to a new level when it teamed up with…